D-Index & Metrics Best Publications

Christopher D.M. Fletcher

Brigham and Women's Hospital
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 163 Citations 110,420 694 World Ranking 370 National Ranking 236

Best Scientists D-index 163 Citations 110,420 694 World Ranking 734 National Ranking 464

Research.com Recognitions

Awards & Achievements

2023 - Research.com Best Scientist Award

2022 - Research.com Best Scientist Award

Overview

What is he best known for?

The fields of study Christopher D.M. Fletcher is best known for:

Global warming
Meteorology
Climate change

Climatology is closely attributed to Forcing (mathematics) in his study. His study ties his expertise on Atmospheric sciences together with the subject of Forcing (mathematics). Many of his studies on Atmospheric sciences apply to Atmospheric circulation as well. Christopher D.M. Fletcher performs integrative study on Atmospheric circulation and Teleconnection in his works. The study of Meteorology is intertwined with the study of Atmosphere (unit) in a number of ways. His research on Atmosphere (unit) often connects related topics like Meteorology. His research brings together the fields of Atmospheric model and Oceanography. His study on Atmospheric model is mostly dedicated to connecting different topics, such as Oceanography. Snow is closely attributed to Geomorphology in his work.

His most cited work include:

The CCSM4 Land Simulation, 1850–2005: Assessment of Surface Climate and New Capabilities (260 citations)
The Role of Linear Interference in the Annular Mode Response to Tropical SST Forcing (117 citations)
The Dynamical Response to Snow Cover Perturbations in a Large Ensemble of Atmospheric GCM Integrations (111 citations)

What are the main themes of his work throughout his whole career to date

His Climate model study focuses on Coupled model intercomparison project and Climate sensitivity. In his works, he undertakes multidisciplinary study on Coupled model intercomparison project and Climate model. His research on Climatology frequently connects to adjacent areas such as Rossby wave. He integrates many fields, such as Meteorology and Physical geography, in his works. Christopher D.M. Fletcher brings together Physical geography and Meteorology to produce work in his papers. As part of his studies on Atmospheric sciences, he often connects relevant subjects like Extratropical cyclone. Much of his study explores Oceanography relationship to Arctic. Arctic and Oceanography are commonly linked in his work. He merges Snow with Precipitation in his research.

Christopher D.M. Fletcher most often published in these fields:

Climatology (78.79%)
Meteorology (72.73%)
Atmospheric sciences (66.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

George Daniel Demetri;Margaret von Mehren;Charles D. Blanke;Annick Diane Van Den Abbeele.
The New England Journal of Medicine (2002)

5237 Citations

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone

Christopher D.M. Fletcher;Krisjnan Unni;Fredrik Mertens.
(2002)

5068 Citations

Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein.
Human Pathology (2002)

4443 Citations

Pathology and genetics of tumours of soft tissue and bone

Christopher D. M. Fletcher;K. Krishnan Unni;Fredrik Mertens.
(2002)

3625 Citations

WHO classification of tumours of soft tissue and bone

Christopher D. M. Fletcher.
(2013)

3552 Citations

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

George D Demetri;Allan T van Oosterom;Christopher R Garrett;Martin E Blackstein.
The Lancet (2006)

2939 Citations

PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

Michael C. Heinrich;Christopher L. Corless;Anette Duensing;Laura McGreevey.
Science (2003)

2860 Citations

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

Michael C. Heinrich;Christopher L. Corless;George D. Demetri;Charles D. Blanke.
Journal of Clinical Oncology (2003)

2703 Citations

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim.
The Lancet (2012)

1775 Citations

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan.
Journal of Clinical Oncology (2008)

1270 Citations

If you think any of the details on this page are incorrect, let us know.